AstraZeneca Total Non-Operating Income/Expense 2010-2024 | AZN

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

AstraZeneca annual total non-operating income/expense for 2023 was $-1.294B, a 3.03% increase from 2022.
AstraZeneca annual total non-operating income/expense for 2022 was $-1.256B, a 4.92% decline from 2021.
AstraZeneca annual total non-operating income/expense for 2021 was $-1.321B, a 6.02% increase from 2020.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

AstraZeneca annual total non-operating income/expense for 2023 was $-1.294B, a 3.03% increase from 2022.
AstraZeneca annual total non-operating income/expense for 2022 was $-1.256B, a 4.92% decline from 2021.
AstraZeneca annual total non-operating income/expense for 2021 was $-1.321B, a 6.02% increase from 2020.